Clinical Trials Browser

Phase 4 × Neoplasms × Other hematologic neoplasm × Clear all

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT04952766 2025-12-23

EREVA

Acquired Immunodeficiency Syndrome, Diabetes Mellitus, Type 2, Hypergammaglobulinemia, Multiple Sclerosis, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT03176849 2020-11-17

A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Phase 4 Completed

49 enrolled

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Hematologic Diseases, Myelodysplastic Syndromes, Neoplasms, Vitamin D Deficiency, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04187755 2019-12-06

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Phase 4 Completed

72 enrolled

Classical hematologyOther hematologic neoplasm

Fever, Leukemia, Neoplasms, Neutropenia, Febrile Neutropenia

NCT02149329 2019-09-25

SHORT

Phase 4 Completed

276 enrolled

Classical hematologyOther hematologic neoplasm

Fever, Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT00230217 2009-03-30

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Phase 4 Completed

94 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms, Recurrence, Tumor Lysis Syndrome, Hyperuricemia

NCT00131313 2005-08-18

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

Phase 4 Unknown

180 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

Clinical Trials

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

EREVA

A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

SHORT

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.